Methotrexate for pain relief in knee osteoarthritis: An open-label study

Rheumatology (United Kingdom)

Volumn 52, Issue 5, 2013, Pages 888-892

  Wenham, Claire Y J ^a,b   Grainger, Andrew J ^b   Hensor, Elizabeth M A ^a   Caperon, Anna R ^a   Ash, Zoe R ^a,b   Conaghan, Philip G ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

Knee; Methotrexate; Osteoarthritis; Pain

Indexed keywords

CODEINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRAMADOL;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; HEADACHE; HIP PAIN; HUMAN; JOINT EFFUSION; KNEE OSTEOARTHRITIS; KNEE PAIN; LETHARGY; NAUSEA; NEUTROPENIA; OPEN STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SYNOVITIS; SYNOVIUM; TREATMENT DURATION; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNOVITIS; TREATMENT OUTCOME;

EID: 84876701109     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes386     Document Type: Article

References (20)

1. Felson DT, Lawrence RC, Dieppe PA et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000; 133: 635-46.
2. Conaghan PG, Dickson J, Grant RL. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 2008; 336: 502-3.
3. Zhang W, Nuki G, Moskowitz RW et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010; 18: 476-99.
4. Hill CL, Gale DG, Chaisson CE et al. Knee effusions, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol 2001; 2: 1330-7.
5. Baker K, Grainger A, Niu J et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis 2010; 69: 1779-83.
6. Zhang Y, Nevitt M, Niu J et al. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum 2011; 63: 691-9.
7. Roemer FW, Kassim Javaid M, Guermazi A et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthritis Cartilage 2010; 18: 1269-74.
8. Hill CL, Hunter DJ, Niu J et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007; 66: 1599-603.
9. Yazici Y. Long-term safety of methotrexate in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 2010; 28: S65-7.
10. Holanda D. Baxia dose de methotrexate comparado a placebo em osteoartrite de joelho. Rev Bras Reumatol 2007; 47: 334-40.
11. Pavelka K. Methotrexate in the treatment of erosive OA of the hands. Ann Rheum Dis 2006; 65: 402.
12. Wakefield RJ, Balint PV, Szkudlarek M et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32: 2485-7.
13. Pham T, van der Heijde D, Altman RD et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004; 12: 389-99.
14. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004; 10: 307-12.
15. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis 2010; 69: 374-9.
16. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372-80.
17. Schnabel A, Herlyn K, Burchardi C, Reinhold-Keller E, Gross WL. Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Rheumatol Int 1996; 15: 195-200.
18. Felson DT, Chaisson CE, Hill CL et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001; 134: 541-9.
19. Hernandez-Molina G, Neogi T, Hunter DJ et al. The association of bone attrition with knee pain and other MRI features of osteoarthritis. Ann Rheum Dis 2008; 67: 43-7.
20. Doherty M, Dieppe P. The "placebo"response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage 2009; 17: 1255-62.